Real-Life Considerations on Antifungal Treatment Combinations for the Management of Invasive Mold Infections after Allogeneic Cell Transplantation.

J Fungi (Basel) · 2021 · PMC8540382 · PMID 34682233

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

showed a trendp = 0.08so close (0.05 < p ≤ 0.1)

Although the differences were non-statistically significant, all types of antifungal combinations were generally longer in duration in non-IA IMI, with the exception of the liposomal amphotericin B/echinocandin combination regimen that showed a trend of an increased duration in the IA vs. non-IA IMI group (33 vs. 6 days, p = 0.08). 3.3.2.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.